Unleashing Precision Medicines and Clinical Success with Targets, Therapeutics, Biomarkers
We integrate machine learning and high-throughput biology to identify key genetic interactions within complex disease networks, pinpointing targets and therapeutics for biomarker-defined patient populations.
Our teams advance these insights towards translation for patients through purposeful design, selection, and development of therapeutics for specific clinical contexts.
Our pipeline addresses a wide range of solid tumors through targeted therapies in specific patient populations, while we work with partners and collaborators in other therapeutic areas.
What We Do
Pinpoint critical disease biology informing new medicines, including targets, biomarkers for patient selection, and combinations
Develop therapeutics and biomarkers by capitalizing on our biology insights
Leverage our repeatable platform to deliver impact for patients and R&D processes
Partner to amplify the impact of our assets, insights, and established platform
As Featured In:
We’d love to hear from you. Please contact us using this form.
21 Biopolis Rd
Nucleos North Tower, #02-03
(within NSG BioLabs)
1400 Bridge Parkway
Redwood City, CA 94065